ICMR Issues Revised Guidelines For Usage Of HCQ As Preventive Medication For Covid-19 Hydroxychloroquine

The Indian Council of Medical Research (ICMR) has issued revised guidelines for use of hydroxychloroquine (HCQ), the malaria drug, as a preventive medication for asymptomatic healthcare workers in non-Covid-19 hospitals, frontline staff on surveillance duty in containment zones and paramilitary/police personnel involved in coronavirus infection related activities.

"The Joint Monitoring Group and the NTF have recommended prophylactic use of HCQ in asymptomatic frontline workers, such as surveillance workers deployed in containment zones and paramilitary/police personnel involved in Covid-19 related activities, asymptomatic household contacts of laboratory confirmed cases and all asymptomatic healthcare workers involved in containment and treatment of Covid-19 and working in non-Covid hospitals/non-Covid areas of Covid hospitals/blocks," the ICMR said, here on Saturday (23 May).

The ICMR revised the guidelines to expand use of this anti-malarial drug as a preventive treatment against coronavirus.

Stating that HCQ is relatively safe, when certain contra-indications are avoided, the ICMR said it had some beneficial effect as a prophylactic option. However, the drug should be given under strict medical supervision with an informed consent and only on the prescription of a registered medical practitioner, it said.

The ICMR said electrocardiogram (ECG) shall be done before prescribing HCQ prophylaxis and in case any new cardiovascular symptom it would be mandatory, the advisory said.

The drug should not be recommended for prophylaxis in children under 15 years of age and in pregnancy and lactation, it said.

This news has been published via Syndicate feed. Only the headline is changed.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber
Advertisement